Literature DB >> 25319795

Obesity increases histone H3 lysine 9 and 18 acetylation at Tnfa and Ccl2 genes in mouse liver.

Michal Mikula1, Aneta Majewska2, Joanna Karolina Ledwon2, Artur Dzwonek1, Jerzy Ostrowski1.   

Abstract

Obesity contributes to the development of non-alcoholic fatty liver disease (NAFLD), which is characterized by the upregulated expression of two key inflammatory mediators: tumor necrosis factor (Tnfa) and monocyte chemotactic protein 1 (Mcp1; also known as Ccl2). However, the chromatin make-up at these genes in the liver in obese individuals has not been explored. In this study, to identify obesity-mediated epigenetic changes at Tnfa and Ccl2, we used a murine model of obesity induced by a high-fat diet (HFD) and hyperphagic (ob/ob) mice. Chromatin immunoprecipitation (ChIP) assay was used to determine the abundance of permissive histone marks, namely histone H3 lysine 9 and 18 acetylation (H3K9/K18Ac), H3 lysine 4 trimethylation (H3K4me3) and H3 lysine 36 trimethylation (H3K36me3), in conjunction with polymerase 2 RNA (Pol2) and nuclear factor (Nf)-κB recruitment in the liver. Additionally, to correlate the liver tissue-derived ChIP measurements with a robust in vitro transcriptional response at the Tnfa and Ccl2 genes, we used lipopolysaccharide (LPS) treatment to induce an inflammatory response in Hepa1-6 cells, a cell line derived from murine hepatocytes. ChIP revealed increased H3K9/K18Ac at Tnfa and Ccl2 in the obese mice, although the differences were only statistically significant for Tnfa (p<0.05). Unexpectedly, the levels of H3K4me3 and H3K36me3 marks, as well as Pol2 and Nf-κB recruitment, did not correspond with the increased expression of these two genes in the obese mice. By contrast, the acute treatment of Hepa1-6 cells with LPS significantly increased the H3K9/K18Ac marks, as well as Pol2 and Nf-κB recruitment at both genes, while the levels of H3K4me3 and H3K36me3 marks remained unaltered. These results demonstrate that increased Tnfa and Ccl2 expression in fatty liver at the chromatin level corresponds to changes in the level of histone H3 acetylation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25319795     DOI: 10.3892/ijmm.2014.1958

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  17 in total

Review 1.  Endocrine-disrupting chemicals and fatty liver disease.

Authors:  Charles E Foulds; Lindsey S Treviño; Brian York; Cheryl L Walker
Journal:  Nat Rev Endocrinol       Date:  2017-05-19       Impact factor: 43.330

2.  Developmental programming: Prenatal testosterone-induced changes in epigenetic modulators and gene expression in metabolic tissues of female sheep.

Authors:  Xingzi Guo; Muraly Puttabyatappa; Steven E Domino; Vasantha Padmanabhan
Journal:  Mol Cell Endocrinol       Date:  2020-06-17       Impact factor: 4.102

Review 3.  Dietary natural products as epigenetic modifiers in aging-associated inflammation and disease.

Authors:  Levi W Evans; Matthew S Stratton; Bradley S Ferguson
Journal:  Nat Prod Rep       Date:  2020-01-29       Impact factor: 13.423

Review 4.  Epigenetic Aspects and Prospects in Autoimmune Hepatitis.

Authors:  Albert J Czaja
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

5.  The differential effects of low birth weight and Western diet consumption upon early life hepatic fibrosis development in guinea pig.

Authors:  Ousseynou Sarr; Alexandra Blake; Jennifer A Thompson; Lin Zhao; Katherine Rabicki; Joanna C Walsh; Ian Welch; Timothy R H Regnault
Journal:  J Physiol       Date:  2016-02-17       Impact factor: 5.182

Review 6.  Metabolic regulation of kisspeptin - the link between energy balance and reproduction.

Authors:  Víctor M Navarro
Journal:  Nat Rev Endocrinol       Date:  2020-05-19       Impact factor: 43.330

Review 7.  Potential epigenetic mechanism in non-alcoholic Fatty liver disease.

Authors:  Chao Sun; Jian-Gao Fan; Liang Qiao
Journal:  Int J Mol Sci       Date:  2015-03-05       Impact factor: 5.923

8.  Liver Adiposity and Metabolic Profile in Individuals with Chronic Spinal Cord Injury.

Authors:  Kathleen C Rankin; Laura C O'Brien; Liron Segal; M Rehan Khan; Ashraf S Gorgey
Journal:  Biomed Res Int       Date:  2017-08-30       Impact factor: 3.411

9.  Tannic acid, a novel histone acetyltransferase inhibitor, prevents non-alcoholic fatty liver disease both in vivo and in vitro model.

Authors:  Min-Yu Chung; Ji-Hye Song; Jinhyuk Lee; Eun Ju Shin; Jae Ho Park; Seung-Hyun Lee; Jin-Taek Hwang; Hyo-Kyoung Choi
Journal:  Mol Metab       Date:  2018-11-10       Impact factor: 7.422

10.  BAM15, a Mitochondrial Uncoupling Agent, Attenuates Inflammation in the LPS Injection Mouse Model: An Adjunctive Anti-Inflammation on Macrophages and Hepatocytes.

Authors:  Cong Phi Dang; Jiraphorn Issara-Amphorn; Awirut Charoensappakit; Kanyarat Udompornpitak; Thansita Bhunyakarnjanarat; Wilasinee Saisorn; Kritsanawan Sae-Khow; Asada Leelahavanichkul
Journal:  J Innate Immun       Date:  2021-06-01       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.